Glioma clinical trials
Showing 51–80 of 80 active trials. Describe your situation to see which ones you may be eligible for.
- Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1
- Glioma Developmental and HyperActive Ras Tumor (DHART) Board
- Registering Genomics and Imaging of Tumors (ReGIT)
- Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma
- Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
- Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
- Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors
- Telehealth Visits to Discuss Advanced Directives for Patients Newly Diagnosed With High Grade Glioma
- Intraoperative Fluorescence-Guided Aspirate Tissue Monitoring of 5-ALA During Brain Tumor Surgery
- NeuroPathways Intervention for Brain Tumor Patients
- Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
- ASCENT Intervention for Brain Tumor Patients
- High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility Study
- Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
- Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies
- Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
- Integrating Biology for Safe Intensification of Glioblastoma Hypofractionated Treatment on the MR-Linac
- A Study of CS231295 in Patients With Advanced Solid Tumors
- Movie-Watching Functional MRI for Mapping Brain Function in Neurosurgical Patients
- Residual IDH1-Mutant Tumor Cell Quantification Study
- Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICG
- MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors
- A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers
- Navigating the Clinical Research Process for Glioma
- Language Network Prehab Via fMRI Neurofeedback
- A Study for Cerebral Open Flow Microperfusion
- Living Well With Brain Cancer: A Group-Based Intervention to Promote Whole-Person Well-Being
- Ultralow Dose PET Imaging of 18F-FDOPA
- A Study of Avutometinib for People With Solid Tumor Cancers
- Fitness and Nutrition in Glioma
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.